Deal Announcements

AgaMatrix Raises Funding For European Expansion

Wednesday, January 02, 2008 5:55:00 AM PDT | VentureDeal Staff

SALEM, NH - Medical device maker AgaMatrix said that it has secured $23.7 million in funding from new and existing investors.

AgaMatrix developed and markets the WaveSense line of blood glucose monitoring and data management systems for patients with diabetes.  The company has four patented FDA-cleared products.

Ferrer Freeman & Co. led the round.  The company said it intends to expand its sales and marketing operations in Europe while it prepares for a potential IPO in the United States.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1